CN109897001B - 一种含二取代肼基的酯类化合物、制备方法及应用 - Google Patents

一种含二取代肼基的酯类化合物、制备方法及应用 Download PDF

Info

Publication number
CN109897001B
CN109897001B CN201711343509.6A CN201711343509A CN109897001B CN 109897001 B CN109897001 B CN 109897001B CN 201711343509 A CN201711343509 A CN 201711343509A CN 109897001 B CN109897001 B CN 109897001B
Authority
CN
China
Prior art keywords
hydrazino
oxy
carboxylic acid
chlorophenyl
vinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201711343509.6A
Other languages
English (en)
Other versions
CN109897001A (zh
Inventor
杨春龙
张立志
时松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Agricultural University
Original Assignee
Nanjing Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Agricultural University filed Critical Nanjing Agricultural University
Priority to CN201711343509.6A priority Critical patent/CN109897001B/zh
Publication of CN109897001A publication Critical patent/CN109897001A/zh
Application granted granted Critical
Publication of CN109897001B publication Critical patent/CN109897001B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

本发明属于杀菌剂领域,公开了一种含二取代肼基的酯类化合物、制备方法及应用,该类化合物的结构如式(I)所示:

Description

一种含二取代肼基的酯类化合物、制备方法及应用
技术领域
本发明涉及一种含二取代肼基的酯类化合物、制备方法及其在防治植物病原真菌方面的应用,具有制备农药杀菌剂的用途。
背景技术
肼与酯基团均为农药分子结构中常见的活性基团。消螨通(dinobuton)和消螨多(meptyldinocap)均含碳酸酯基团,具有良好的杀螨活性,并能有效防治作物白粉病。氨基甲酸酯类杀虫剂,如西维因(carbaryl)等被广泛应用于害虫的防治;乙霉威(diethofencarb)属于氨基甲酸酯类杀菌剂,用于作物灰霉病的防治。专利CN1692099介绍了含酯基团的螺环吡咯啉酮类化合物,该类化合物具有优异的杀虫活性。专利CN103183628A介绍了一种含取代肼基的吡咯烷二酮类化合物的制备方法及应用,该类化合物具有良好的抑制真菌活性。
发明内容
本发明的目的在于,提供一种含二取代肼基的酯类化合物。
本发明的另一目的在于提供含二取代肼基的酯类化合物的制备方法。
本发明的另一个目的在于提供上述化合物的用途。
本发明的第一方面提供了一种具有通式(I)所示结构的含二取代肼基的酯类化合物,
Figure BSA0000155617530000011
在式(I)中,所述各个基团具有如下所述的定义:
R1选自氢、C1-12烷基;
R2选自氢、C1-12烷基;
R3选自C1-12烷基、苯甲基、取代苯甲基,所述的取代基团选自1-3个卤素、1-2个C1-6烷基;
Z选自N-R4、CH-R5、O、S,所述的R4、R5各自独立地选自氢、C1-12烷基、C3-8环烷基、C1-12烷酰基、苯基、取代苯基、苯甲基、取代苯甲基,所述的取代基团选自1-3个卤素、1-2个C1-6烷基、1-2个C1-6烷氧基、1-3个NO2
Y(n)中,n=1-5取代,Y(n)选自下列1-5个基团:X、R’、OR”、NO2,其中X表示卤素;R’表示未取代或被1个或多个卤素取代的C1-6烷基;R”表示氢、未取代或被1个或多个卤素取代的C1-6烷基。
在式(I)中,所述各个基团具有如下所述的优选定义:
R1选自氢、C1-6烷基;
R2选自氢、C1-6烷基;
R3选自C1-6烷基、苯甲基;
Z选自N-R4、CH-R5,所述的R4、R5各自独立地选自氢、C1-6烷基、C3-6环烷基、C1-6烷酰基、苄基,R5选自氢;
Y(n)中,n=1-3取代,Y(n)选自下列1-3个基团:卤素、C1-6烷基、C1-6烷氧基。
在式(I)中,所述各个基团具有如下所述的进一步优选定义:
R1选自氢、甲基;
R2选自氢;
R3选自甲基、乙基、丙基、异丙基、丁基、异丁基、苯甲基;
Z选自N-R4,所述的R4选自氢、甲基、乙基、环丙基、环己基、乙酰基、苯甲基;
Y(n)选自2-氟、4-氟、2-氯、3-氯、4-氯、4-溴、2,4-二氯、4-甲基、3,4-二甲基、4-甲氧基;
或者,
R1选自氢;
R2选自氢;
R3选自甲基、乙基、丙基、异丙基、丁基、异丁基、苄基;
Z选自CH-R5,所述的R5选自氢;
Y(n)选自2-氟、4-氟、2-氯、3-氯、4-氯、4-溴、4-甲基、4-甲氧基。
在式(I)中,所述各个基团具有如下所述的特别优选定义:
1-(1-(4-((甲氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸甲酯、
1-(1-(4-((乙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸乙酯、
1-(1-(4-((丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((丁氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丁酯、
1-(1-(4-((异丁氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丁酯、
1-(1-(4-((苄氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸苄酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-甲基苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-甲氧基苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(3,4-二甲基苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2-氟苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氟苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(3-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2,4-二氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-溴苯基)肼基-1-甲酸异丙酯、
1-(1-(1-甲基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-乙基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-乙酰基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-环丙基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-环己基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-苄基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-5-甲基-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(2-((甲氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸甲酯、
1-(1-(2-((乙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸乙酯、
1-(1-(2-((丙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丙酯、
1-(1-(2-((异丙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丁酯、
1-(1-(2-((异丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丁酯、
1-(1-(2-((苄氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸苄酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(2-氟苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氟苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(2-氯苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(3-氯苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-溴苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-甲苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-甲氧基苯基)肼基-1-甲酸丁酯。
本发明的第二个方面提供了制备式(I)的含二取代肼基的酯类化合物的方法,该方法以式(II)的化合物与氯甲酸酯反应,制备式(I)的含二取代肼基的酯类化合物,其反应方程式可用下述通式(A)表示:
Figure BSA0000155617530000031
其中在上述各结构式中:
R1、R2、R3、Z、Y(n)均具有如前所述的相应基团的定义。
构式中含五元杂环、苯肼、甲酸酯三种特征基团;五元杂环是饱和的吡唑烷的二元酮;甲酸酯基团连接在肼基的1位N原子上;五元环和肼基之间通过一个含双键的亚烃基连接。
2、本发明专利所述的式(I)的含吡唑烷二酮和苯肼基团的甲酸酯类化合物的制备方法简便、原料易得、产率高。
3、本发明专利所述的式(I)的含吡唑烷二酮和苯肼基团的甲酸酯类化合物表现出显著的抑制植物病原真菌的活性,具有作为农药杀菌剂的用途。
具体实施方式
本发明的实质性特点可从下述实施例得以体现,但它不应视为是对本发明的任何限制。
制备实施例
实施例1:含吡唑烷二酮和苯肼基团的甲酸酯类化合物A1的制备
在冰浴条件下,在50mL三口瓶中加入20mL二氯甲烷、1.9mmol化合物(II-A1)和5mL三乙胺,搅拌,缓慢滴加2.1mmol氯甲酸甲酯,用TLC监控反应进程,反应完成后,用水洗涤,干燥,蒸除溶剂,经重结晶提纯(溶剂为乙醚与石油醚按照体积比10∶1配制的混合溶液),得含吡唑烷二酮和苯肼基团的甲酸酯类化合物A1,其反应方程式如下:
Figure BSA0000155617530000041
采用实施例1的方法,制备了含吡唑烷二酮和苯肼基团的甲酸酯类化合物(I)中的A、B、C、D、E系列化合物:
1-(1-(3,5-二氧吡唑烷-4-基亚基)乙基)-2-(4-氯苯基)肼基甲酸甲酯(A1)
Figure BSA0000155617530000042
Yellow powder,yield 40.3%;m.p.141.5-142.8℃;IR(KBr,cm-1)v:3220,2919,1716,1598,1533,1489,1436,1276,1240,1031,830,610;1H NMR(400MHz,DMSO-d6)δ:10.66(s,1H,ArNHN),9.13(s,1H,CONH),7.23(s,1H,CONH),7.17(d,J=8.6Hz,2H,ArH),6.67(d,J=8.2Hz,2H,ArH),3.77(s,3H,COOCH3),2.21(s,3H,C=CCH3);MS(EI)m/z:296[M-30]+.
1-(1-(3,5-二氧吡唑烷-4-基亚基)乙基)-2-(4-氯苯基)肼基甲酸乙酯(A2)
Figure BSA0000155617530000043
Yellow powder,yield 44.1%;m.p.120.9-122.1℃;IR(KBr,cm-1)v:3271,2981,1717,1686,1598,1544,1464,1368,1231,1010,897,611;1H NMR(400MHz,DMSO-d6)δ:9.05(s,1H,ArNHN),8.54(s,2H,CONH),7.17(d,J=8.4Hz,2H,ArH),6.66(d,J=8.2Hz,2H,ArH),4.26(q,J=6.7Hz,2H,COOCH2),2.40(s,3H,C=CCH3),1.26(t,J=6.9Hz,3H,COOCH2CH3);MS(EI)m/z:296[M-44]+.
1-(1-(3,5-二氧吡唑烷-4-基亚基)乙基)-2-(4-氯苯基)肼基甲酸正丙酯(A3)
Figure BSA0000155617530000051
白色粉末,收率73.5%,m.p.175.7-177.4℃;IR(KBr,cm-1)v:3291,3216,3098,2950,2921,1764,1718,1693,1678,1599,1491,1439,1392;1H NMR(400MHz,DMSO)δ:8.24(s,1H,PhNH),8.20(s,1H,CH2NH),7.17(d,J=8.8Hz,2H,PhH),6.89(d,J=8.9Hz,2H,PhH),5.34(s,1H,C=CH2),5.28(s,1H,C=CH2),4.26(s,2H,CH2NH),3.84(s,3H,OCH3),3.57(s,3H,OCH3);MS(EI)m/z:382[M]+.
1-(1-(4-((乙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸乙酯(A2)
Figure BSA0000155617530000052
白色粉末,收率58.3%,m.p.141.5-146.2℃;IR(KBr,cm-1)v:3350,3219,3090,2999,2974,1781,1687,1633,1598,1515,1489,1439,1370;1H NMR(400MHz,DMSO)δ:8.27(s,1H,PhNH),8.18(s,1H,CH2NH),7.17(d,J=8.8Hz,2H,PhH),6.90(d,J=8.8Hz,2H,PhH),5.29(s,1H,C=CH2),5.14(s,1H,C=CH2),4.30-4.22(m,4H,CH2NH+OCH2),4.00(q,J=7.1Hz,2H,OCH2),1.27(t,J=7.1Hz,3H,CH3),1.08(t,J=7.1Hz,3H,CH3);MS(EI)m/z:410[M]+.
1-(1-(4-((丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丙酯(A3)
Figure BSA0000155617530000053
白色粉末,收率50.7%,m.p.115.6-116.3℃;IR(KBr,cm-1)v:3314,3188,3082,2970,2881,1777,1688,1603,1508,1491,1473,1410,1344;1H NMR(400MHz,DMSO)δ:8.26(s,1H,PhNH),8.19(s,1H,CH2NH),7.17(d,J=8.8Hz,2H,PhH),6.90(d,J=8.8Hz,2H,PhH),5.31(s,1H,C=CH2),5.16(s,1H,C=CH2),4.25(s,2H,CH2NH),4.18(t,J=6.6Hz,2H,OCH2),3.91(t,J=6.4Hz,2H,OCH2),1.74-1.60(m,2H,CH3CH2),1.54-1.39(m,2H,CH3CH2),0.91(t,J=7.4Hz,3H,CH3),0.74(t,J=7.4Hz,3H,CH3);MS(EI)m/z:437[M-H]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(A4)
Figure BSA0000155617530000054
白色粉末,收率80.3%,m.p.162.3-166.4℃;IR(KBr,cm-1)v:3335,3180,3074,2990,2878,1779,1722,1697,1630,1596,1489,1495,1376;1H NMR(400MHz,DMSO)δ:8.28(s,1H,PhNH),8.18(s,1H,CH2NH),7.17(d,J=8.8Hz,2H,PhH),6.91(d,J=8.8Hz,2H,PhH),5.25(s,1H,C=CH2),5.00(s,1H,C=CH2),4.93-4.84(m,1H,CH),4.76-4.64(m,1H,CH),4.25(s,2H,CH2NH),1.29(d,J=6.2Hz,6H,CH(CH3)2),1.08(d,J=6.2Hz,6H,CH(CH3)2);MS(EI)m/z:351[M-87]+.
1-(1-(4-((丁氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丁酯(A5)
Figure BSA0000155617530000061
白色粉末,收率58.8%,m.p.104.6-105.7℃;IR(KBr,cm-1)v:3326,3187,3080,2962,2929,1784,1744,1688,1600,1490,1439,1399;1H NMR(400MHz,DMSO)δ:8.25(s,1H,PhNH),8.19(s,1H,CH2NH),7.17(d,J=8.8Hz,2H,PhH),6.90(d,J=8.8Hz,2H,PhH),5.31(s,1H,C=CH2),5.15(s,1H,C=CH2),4.25(s,2H,CH2NH),4.22(t,J=6.6Hz,2H,OCH2),3.95(t,J=6.4Hz,2H,OCH2),1.69-1.57,1.48-1.29,1.24-1.09(m,8H,2×(CH2)2CH3),0.90(t,J=7.4Hz,3H,CH3),0.78(t,J=7.4Hz,3H,CH3);MS(EI)m/z:465[M-H]+.
1-(1-(4-((异丁氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丁酯(A6)
Figure BSA0000155617530000062
白色粉末,收率68.2%,m.p.102.1-105.5℃;IR(KBr,cm-1)v:3327,3227,3096,2960,2874,1782,1694,1601,1489,1401,1380;1H NMR(400MHz,DMSO)δ:8.24(s,1H,PhNH),8.20(s,1H,CH2NH),7.17(d,J=8.8Hz,2H,PhH),6.91(d,J=8.9Hz,2H,PhH),5.33(s,1H,C=CH2),5.19(s,1H,C=CH2),4.25(s,2H,CH2NH),4.01(d,J=6.6Hz,2H,OCH2),3.74(d,J=6.4Hz,2H,OCH2),2.03-1.88(m,1H,CH),1.79-1.65(m,1H,CH),0.91(d,J=6.7Hz,6H,CH(CH3)2),0.73(d,J=6.7Hz,6H,CH(CH3)2);MS(EI)m/z:465[M-H]+.
1-(1-(4-((苄氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸苄酯(A7)
Figure BSA0000155617530000063
白色粉末,收率56.4%,m.p.166.3-167.2℃;IR(KBr,cm-1)v:3295,3212,3094,2961,2901,1764,1715,1694,1599,1491,1457,1375;1H NMR(400MHz,DMSO)δ:8.36(s,1H,PhNH),8.19(s,1H,CH2NH),7.47-7.35(m,5H,PhH),7.31-7.23(m,3H,PhH),7.20-7.10(m,4H,PhH),6.95-6.86(m,2H,PhH),5.33(s,1H,C=CH2),5.26(s,2H,CH2Ph),5.19(s,1H,C=CH2),5.00(s,2H,CH2Ph),4.20(s,2H,CH2NH);MS(EI)m/z:534[M]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-甲基苯基)肼基-1-甲酸异丙酯(A8)
Figure BSA0000155617530000071
白色粉末,收率77.9%,m.p.155.2-156.0℃;IR(KBr,cm-1)v:3328,3178,3069,2994,2876,1778,1719,1690,1629,1515,1465,1378;1H NMR(400MHz,DMSO)δ:8.15(s,1H,PhNH),7.84(s,1H,CH2NH),6.95(d,J=8.1Hz,2H,PhH),6.76(d,J=8.1Hz,2H,PhH),5.24(s,1H,C=CH2),5.02(s,1H,C=CH2),4.94-4.83(m,1H,OCH),4.75-4.63(m,1H,OCH),2.17(s,3H,PhCH3),1.30(d,J=6.2Hz,6H,CH(CH3)2),1.07(d,J=6.2Hz,6H,CH(CH3)2);MS(EI)m/z:314[M-103]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-甲氧基苯基)肼基-1-甲酸异丙酯(A9)
Figure BSA0000155617530000072
白色粉末,收率53.0%,m.p.150.3-151.9℃;IR(KBr,cm-1)v:3330,3179,3075,2989,2979,1772,1716,1693,1629,1508,1469,1374;1H NMR(400MHz,DMSO)δ:8.15(s,1H,PhNH),7.68(s,1H,CH2NH),6.83(d,J=8.9Hz,2H,PhH),6.75(d,J=8.9Hz,2H,PhH),5.26(s,1H,C=CH2),5.03(s,1H,C=CH2),4.95-4.82(m,1H,OCH),4.75-4.62(m,1H,OCH),4.23(s,2H,CH2NH),3.66(s,3H,OCH3),1.30(d,J=6.2Hz,6H,CH(CH3)2),1.07(d,J=6.2Hz,6H,CH(CH3)2);MS(EI)m/z:330[M-103]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(3,4-二甲基苯基)肼基-1-甲酸异丙酯(A10)
Figure BSA0000155617530000073
白色粉末,收率59.7%,m.p.152.6-153.7℃;IR(KBr,cm-1)v:3328,3227,3033,2987,2934,1769,1691,1636,1525,1501,1440,1374;1H NMR(400MHz,DMSO)δ:8.15(s,1H,PhNH),7.76(s,1H,CH2NH),6.88(d,J=8.1Hz,1H,PhH),6.68(s,1H,PhH),6.61-6.55(m,1H,PhH),5.24(s,1H,C=CH2),5.01(s,1H,C=CH2),4.95-4.82(m,1H,OCH),4.75-4.63(m,1H,OCH),4.23(s,2H,CH2NH),2.10(d,J=13.9Hz,6H,2×PhCH3),1.29(d,J=6.2Hz,6H,CH(CH3)2),1.08(d,J=6.2Hz,6H,CH(CH3)2);MS(EI)m/z:210[M-221]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2-氟苯基)肼基-1-甲酸异丙酯(A11)
Figure BSA0000155617530000081
白色粉末,收率64.7%,m.p.146.5-147.8℃;IR(KBr,cm-1)v:3342,3175,3072,2990,2883,1766,1720,1691,1631,1501,1497,1450,1378;1H NMR(400MHz,DMSO)δ:8.24(s,1H,PhNH),7.95(s,1H,CH2NH),7.30(t,J=8.0Hz,1H,PhH),7.17-7.05(m,1H,PhH),7.00(t,J=7.6Hz,1H,PhH),6.83-6.69(m,1H,PhH),5.35(s,1H,C=CH2),5.08(s,1H,C=CH2),4.96-4.84(m,1H,OCH),4.78-4.65(m,1H,OCH),4.28(s,2H,CH2NH),1.31(d,J=6.2Hz,6H,CH(CH3)2),1.09(d,J=6.2Hz,6H,CH(CH3)2);MS(EI)m/z:421[M]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氟苯基)肼基-1-甲酸异丙酯(A12)
Figure BSA0000155617530000082
白色粉末,收率67.0%,m.p.142.5-143.3℃;IR(KBr,cm-1)v:3338,3177,3073,2990,2883,1778,1718,1698,1631,1505,1466,1376;1H NMR(400MHz,DMSO)δ:8.17(s,1H,PhNH),8.04(s,1H,CH2NH),6.98(t,J=8.8Hz,2H,PhH),6.94-6.88(m,2H,PhH),5.28(s,1H,C=CH2),5.02(s,1H,C=CH2),4.95-4.83(m,1H,OCH),4.77-4.65(m,1H,OCH),4.25(s,2H,CH2NH),1.30(d,J=6.2Hz,6H,CH(CH3)2),1.08(d,J=6.2Hz,6H,CH(CH3)2);MS(EI)m/z:421[M]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2-氯苯基)肼基-1-甲酸异丙酯(A13)
Figure BSA0000155617530000083
黄色粉末,收率53.2%,m.p.136.5-138.1℃;IR(KBr,cm-1)v:3331,3187,3078,2988,2868,1779,1716,1689,1633,1592,1490,1462,1386;1H NMR(400MHz,DMSO)δ:8.27(s,1H,PhNH),7.70(s,1H,CH2NH),7.29(t,J=8.7Hz,2H,PhH),7.16(t,J=7.7Hz,1H,PhH),6.79(t,J=7.6Hz,1H,PhH),5.40(s,1H,C=CH2),5.21(s,1H,C=CH2),4.95-4.85(m,1H,OCH),4.77-4.66(m,1H,OCH),4.25(s,2H,CH2NH),1.30(d,J=6.2Hz,6H,CH(CH3)2),1.08(d,J=6.1Hz,6H,CH(CH3)2);MS(EI)m/z:438[M]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(3-氯苯基)肼基-1-甲酸异丙酯(A14)
Figure BSA0000155617530000091
黄色粉末;收率65.8%;m.p.178.2-178.5℃;IR(KBr,cm-1)v:3349,3218,3097,2985,2936,1779,1772,1688,1634,1594,1479,1375;1H NMR(400MHz,DMSO)δ:8.46(s,1H,PhNH),8.21(s,1H,CH2NH),7.15(t,J=8.0Hz,1H,PhH),7.01(s,1H,PhH),6.86-6.80(m,1H,PhH),6.78-6.71(m,1H,PhH),5.23(s,1H,C=CH2),4.97(s,1H,C=CH2),4.95-4.83(m,1H,OCH),4.77-4.65(m,1H,OCH),4.25(s,2H,CH2NH),1.29(d,J=6.2Hz,6H,CH(CH3)2),1.09(d,J=6.1Hz,6H,CH(CH3)2);MS(EI)m/z:438[M]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2,4-二氯苯基)肼基-1-甲酸异丙酯(A15)
Figure BSA0000155617530000092
黄色粉末,收率61.5%,m.p.128.4-130.4℃;IR(KBr,cm-1)v:3332,3209,3089,2981,2872,1775,1724,1694,1628,1592,1488,1466,1392;1H NMR(400MHz,DMSO)δ:8.28(s,1H,PhNH),7.97(s,1H,CH2NH),7.46(d,J=2.1Hz,1H,PhH),7.38(d,J=8.8Hz,1H,PhH),7.25-7.18(m,1H,PhH),5.36(s,1H,C=CH2),5.14(s,1H,C=CH2),4.96-4.85(m,1H,OCH),4.78-4.67(m,1H,OCH),4.30(s,2H,CH2NH),1.31(d,J=6.2Hz,6H,CH(CH3)2),1.10(d,J=6.1Hz,6H,CH(CH3)2);MS(EI)m/z:472[M]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-溴苯基)肼基-1-甲酸异丙酯(A16)
Figure BSA0000155617530000093
白色粉末,收率53.6%,m.p.148.0-149.3℃;IR(KBr,cm-1)v:3334,3183,3076,2992,2877,1779,1724,1696,1630,1594,1490,1462,1386;1H NMR(400MHz,DMSO)δ:8.33(s,1H,PhNH),8.20(s,1H,CH2NH),7.29(d,J=8.7Hz,2H,PhH),6.86(d,J=8.7Hz,2H,PhH),5.24(s,1H,C=CH2),5.00(s,1H,C=CH2),4.94-4.82(m,1H,OCH),4.76-4.64(m,1H,OCH),4.25(s,2H,CH2NH),1.29(d,J=6.2Hz,6H,CH(CH3)2),1.08(d,J=6.1Hz,6H,CH(CH3)2);MS(EI)m/z:482[M]+.
1-(1-(1-甲基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(A17)
Figure BSA0000155617530000101
白色粉末,收率61.3%,m.p.133.6-135.2℃;IR(KBr,cm-1)v:3249,3099,2981,2934,1777,1715,1689,1668,1598,1490,1464,1375;1H NMR(400MHz,DMSO)δ:8.30(s,1H,NH),7.17(d,J=8.8Hz,2H,PhH),6.93(d,J=8.9Hz,2H,PhH),5.25(s,1H,C=CH2),4.99(s,1H,C=CH2),4.95-4.83(m,1H,OCH),4.76-4.64(m,1H,OCH),4.36(s,2H,CH2NH),2.92(s,3H,CH3N),1.30(d,J=6.2Hz,6H,CH(CH3)2),1.06(d,J=6.2Hz,6H,CH(CH3)2);MS(EI)m/z:452[M]+.
1-(1-(1-乙基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(A18)
Figure BSA0000155617530000102
白色粉末,收率55.4%,m.p.120.2-121.6℃;1R(KBr,cm-1)v:3249,3099,2981,2934,1777,1715,1689,1668,1598,1490,1464,1375;1H NMR(400MHz,DMSO)δ:8.25(s,1H,NH),7.17(d,J=8.7Hz,2H,PhH),6.93(d,J=8.8Hz,2H,PhH),5.26(s,1H,C=CH2),5.00(s,1H,C=CH2),4.95-4.83(m,1H,OCH),4.76-4.64(m,1H,OCH),4.36(s,2H,CH2NH),3.40(q,J=7.1Hz,2H,CH3CH2N),1.30(d,J=6.2Hz,6H,CH(CH3)2),1.15-1.01(m,9H,CH(CH3)2+CH3CH2N);MS(EI)m/z:362[M-104]+.
1-(1-(1-乙酰基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(A19)
Figure BSA0000155617530000103
白色粉末,收率68.7%,m.p.127.3-128.5℃;IR(KBr,cm-1)v:3298,3091,2988,2938,1783,1720,1689,1620,1595,1489,1442,1352;1H NMR(400MHz,DMSO)δ:8.38(s,1H,NH),7.19(d,J=8.8Hz,2H,PhH),6.87(d,J=8.9Hz,2H,PhH),5.34(s,1H,C=CH2),4.99(s,1H,C=CH2),4.97-4.86(m,1H,OCH),4.79-4.67(m,3H,OCH+CH2NH),2.45(s,3H,CH3CO),1.31(d,J=6.2Hz,6H,CH(CH3)2),1.08(d,J=6.1Hz,6H,CH(CH3)2);MS(EI)m/z:480[M]+.
1-(1-(1-环丙基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(A20)
Figure BSA0000155617530000111
白色粉末,收率49.2%,m.p.147.9-149.1℃;IR(KBr,cm-1)v:3249,3098,2987,2935,1773,1715,1697,1682,1593,1490,1466,1364;1H NMR(400MHz,DMSO)δ:8.27(s,1H,NH),7.17(d,J=8.8Hz,2H,PhH),6.92(d,J=8.8Hz,2H,PhH),5.25(s,1H,C=CH2),4.97(s,1H,C=CH2),4.93-4.83(m,1H,OCH),4.75-4.64(m,1H,OCH),4.29(s,2H,CH2NH),2.77-2.68(m,1H,NCH),1.29(d,J=6.2Hz,6H,CH(CH3)2),1.07(d,J=6.2Hz,6H,CH(CH3)2),0.77-0.68(m,4H,C2H4);MS(EI)m/z:478[M]+.
1-(1-(1-环己基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(A21)
Figure BSA0000155617530000112
白色粉末,收率58.9%,m.p.151.0-152.0℃;IR(KBr,cm-1)v:3255,3098,2985,2939,2857,1771,1712,1691,1667,1597,1488,1466,1385;1H NMR(400MHz,DMSO)δ:8.26(s,1H,NH),7.17(d,J=8.8Hz,2H,PhH),6.94(d,J=8.8Hz,2H,PhH),5.26(s,1H,C=CH2),4.99(s,1H,C=CH2),4.94-4.83(m,1H,OCH),4.75-4.64(m,1H,OCH),4.31(s,2H,CH2NH),3.94-3.81(m,1H,NCH),1.83-1.56,1.49-1.32,1.18-1.09(m,10H,C5H10),1.30(d,J=6.2Hz,6H,CH(CH3)2),1.07(d,J=6.2Hz,6H,CH(CH3)2);MS(EI)m/z:329[M-191]+.
1-(1-(1-苄基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(A22)
Figure BSA0000155617530000113
白色粉末,收率48.8%,m.p.117.0-118.9℃;IR(KBr,cm-1)v:3260,3033,2981,2920,1769,1714,1685,1597,1491,1412,1390;1H NMR(400MHz,DMSO)δ:8.31(s,1H,PhNH),7.36(t,J=7.2Hz,2H,PhH),7.28(dd,J=14.2,7.2Hz,3H,PhH),7.18(d,J=8.7Hz,2H,PhH),6.93(d,J=8.7Hz,2H,PhH),5.30(s,1H,C=CH2),5.06(s,1H,C=CH2),4.92-4.78(m,1H,OCH),4.77-4.65(m,1H,OCH),4.59(s,2H,CH2NH),4.30(s,2H,PhCH2),1.27(d,J=6.2Hz,6H,CH(CH3)2),1.05(d,J=6.1Hz,6H,CH(CH3)2);MS(EI)m/z:528[M]+.
1-(1-(4-((异丙氧基甲酰基)氧基)-5-甲基-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(A23)
Figure BSA0000155617530000121
棕色油状物,收率41.2%,IR(KBr,cm-1)v:3275,2981,2935,2877,1768,1697,1645,1596,1490,1466,1373;1H NMR(400MHz,DMSO)δ:8.35(s,1H,PhNH),8.33(s,1H,CHNH),7.17(d,J=8.8Hz,2H,PhH),6.92(d,J=8.9Hz,2H,PhH),5.20(s,1H,C=CH2),4.97-4.87(m,1H,C=CH2),4.86(s,1H,CHNH),4.77-4.68(m,1H,OCH),4.49-4.40(m,1H,OCH),1.30(t,J=5.9Hz,6H,CH(CH3)2),1.23(d,J=6.7Hz,3H,CH3CH),1.09(d,J=6.3Hz,6H,CH(CH3)2);MS(EI)m/z:452[M]+.
1-(1-(2-((甲氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸甲酯(B1)
Figure BSA0000155617530000122
土黄色粉末,收率46.0%,m.p.122.1-122.5℃;IR(KBr,cm-1)v:3247,3221,2988,2980,2952,2900,1784,1662,1621,1439;1H NMR(400MHz,DMSO)δ:8.35(s,1H,NH),7.18(d,J=8.8Hz,2H,PhH),6.84(d,J=8.8Hz,2H,PhH),5.27(s,1H,C=CH2),4.94(s,1H,C=CH2),3.86(s,3H,OCH3),3.56(s,3H,OCH3),3.04-2.98(m,2H,CH2CH2),2.56-2.52(m,2H,CH2CH2);MS(EI)m/z:380[M]+.
1-(1-(2-((乙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸乙酯(B2)
Figure BSA0000155617530000123
灰白色粉末,收率35.1%,m.p.121.6-124.3℃;IR(KBr,cm-1)v:3273,3258,2987,2973,2965,2950,1781,1659,1631,1440;1H NMR(400MHz,DMSO)δ:8.35(s,1H,NH),7.18(d,J=8.8Hz,2H,PhH),6.85(d,J=8.8Hz,2H,PhH),5.23(s,1H,C=CH2),4.85(s,1H,C=CH2),4.28(q,J=7.1Hz,2H,OCH2),3.99(q,J=7.1Hz,2H,OCH2),2.99(dd,J=5.1,2.2Hz,2H,CH2CH2),2.55-2.52(m,2H,CH2CH2),1.28(t,J=7.1Hz,3H,CH3),1.06(t,J=7.1Hz,3H,CH3);MS(EI)m/z:408[M]+.
1-(1-(2-((丙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丙酯(B3)
Figure BSA0000155617530000124
黄色粉末,收率49.1%,m.p.111.3-112.5℃;IR(KBr,cm-1)v:3281,3273,2973,2965,2951,2922,1614,1490,1469,1453;1H NMR(400MHz,DMSO)δ:8.33(s,1H,NH),7.17(d,J=8.8Hz,2H,PhH),6.85(d,J=8.8Hz,2H,PhH),5.25(s,1H,C=CH2),4.85(s,1H,C=CH2),4.19(t,J=6.4Hz,2H,OCH2),3.90(t,J=6.4Hz,2H,OCH2),3.08-2.93(m,2H,CH2CH2),2.56-2.52(m,2H,CH2CH2),1.72-1.63(m,2H,CH3CH2),1.48-1.39(m,2H,CH3CH2),0.91(t,3H,CH3),0.72(t,3H,CH3);MS(EI)m/z:436[M]+.
1-(1-(2-((异丙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯(B4)
Figure BSA0000155617530000131
白色粉末,收率40.1%,m.p.110.4-112.7℃;IR(KBr,cm-1)v:3282,3269,2981,2967,2949,2932,1615,1487,1472,1458;1H NMR(400MHz,DMSO)δ:8.32(s,1H,NH),7.18(d,J=8.8Hz,2H,PhH),6.85(d,J=8.8Hz,2H,PhH),5.20(s,1H,C=CH2),4.96-4.85(m,1H,OCH),4.75(s,1H,C=CH2),4.69(dt,J=12.4,6.2Hz,1H,OCH),3.01-2.96(m,2H,CH2CH2),2.56-2.52(m,2H,CH2CH2),1.30(d,J=6.2Hz,6H,CH(CH3)2),1.06(d,J=6.1Hz,6H,CH(CH3)2);MS(EI)m/z:436[M]+.
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丁酯(B5)
Figure BSA0000155617530000132
粉红色粉末,收率51.1%,m.p.104.2-106.4℃;IR(KBr,cm-1)v:3337,3000,2962,2930,2922,1772,1723,1690,1620,1599,1494,1472;1H NMR(400MHz,DMSO)δ:8.34(s,1H,NH),7.18(d,J=8.8Hz,2H,PhH),6.85(d,J=8.8Hz,2H,PhH),5.25(s,1H,C=CH2),4.84(s,1H,C=CH2),4.23(t,J=6.5Hz,2H,OCH2),3.94(t,J=6.3Hz,2H,OCH2),3.05-2.94(m,2H,CH2CH2),2.53(dd,J=5.0,2.2Hz,2H,CH2CH2),1.69-1.59,1.45-1.34,1.14(m,8H,2×(CH2)2CH3),0.90(t,J=7.4Hz,3H,CH3),0.77(t,J=7.4Hz,3H,CH3);MS(EI)m/z:464[M]+.
1-(1-(2-((异丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丁酯(B6)
Figure BSA0000155617530000133
棕色粉末,收率49.9%,m.p.111.3-112.2℃;IR(KBr,cm-1)v:3322,2998,2962,2922,1772,1723,1690,1655,1620,1599,1494,1460;1H NMR(400MHz,DMSO)δ:8.32(s,1H,NH),7.18(d,J=8.8Hz,2H,PhH),6.86(d,J=8.9Hz,2H,PhH),5.27(s,1H,C=CH2),4.87(s,1H,C=CH2),4.03(d,J=6.6Hz,2H,OCH2,3.73(d,J=6.3Hz,2H,OCH2),3.03-2.97(m,2H,CH2CH2),2.55-2.52(m,2H,CH2CH2)),2.08-1.87(m,1H,CH(CH3)2),1.82-1.63(m,1H,CH(CH3)2),0.91(d,J=6.7Hz,6H,CH(CH3)2),0.72(d,J=6.7Hz,6H,CH(CH3)2);MS(EI)m/z:464[M]+.
1-(1-(2-((苄氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸苄酯(B7)
Figure BSA0000155617530000141
棕色粉末,收率31.9%,m.p.113.4-114.8℃;IR(KBr,cm-1)v:3313,2987,2972,2933,2900,1740,1693,1600,1566,1545,1489;1H NMR(400MHz,DMSO)δ;8.44(s,1H,NH),7.42(ddd,J=7.1,6.4,3.4Hz,5H,PhH),7.31-7.24(m,3H,PhH),7.14(dd,J=10.8,6.4Hz,4H,PhH),6.86(d,J=8.8Hz,2H,PhH),5.29(s,2H,C=CH2),5.26(s,1H,C=CH2),4.99(s,2H,OCH2),4.83(s,2H,OCH2),2.90(d,J=3.3Hz,2H,CH2CH2),2.39(s,2H,CH2CH2);MS(EI)m/z:532[M]+.
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(2-氟苯基)肼基-1-甲酸丁酯(B8)
Figure BSA0000155617530000142
棕色粉末,收率32.5%,m.p.111.6-111.8℃;IR(KBr,cm-1)v:3319,2960,2934,2890,2874,1706,1651,1583,1502,1455,1423;1H NMR(400MHz,DMSO)δ:8.07(s,1H,NH),7.18(t,J=8.0Hz,1H,PhH),7.13-7.05(m,1H,PhH),6.99(t,J=7.5Hz,1H,PhH),6.76(dd,J=11.4,7.6Hz,1H,PhH),5.29(s,1H,C=CH2),4.83(s,1H,C=CH2),4.24(t,J=6.5Hz,2H,OCH2),3.93(t,J=6.4Hz,OCH2),3.00(d,J=4.8Hz,2H,CH2CH2),2.55(d,J=4.7Hz,12H,CH2CH2),1.71-1.58(m,2H,CH2CH2CH3),1.37(dt,J=15.1,7.5Hz,4H,2×CH2CH3),1.12(dd,J=14.8,7.3Hz,2H,CH2CH2CH3),0.90(t,J=7.4Hz,3H,CH3),0.76(t,J=7.4Hz,3H,CH3);MS(EI)m/z:448[M]+.
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氟苯基)肼基-1-甲酸丁酯(B9)
Figure BSA0000155617530000143
红棕色粉末,收率31.5%,m.p.110.8-111.2℃;IR(KBr,cm-1)v:3298,2960,2934,2890,2873,1777,1715,1657,1506,1471,1433;1H NMR(400MHz,DMSO)δ:8.10(s,1H,NH),6.98(t,J=8.9Hz,2H,PhH),6.87-6.81(m,2H,PhH),5.26(s,1H,C=CH2),4.84(s,1H,C=CH2),4.24(t,J=6.6Hz,2H,OCH2),3.93(t,J=6.4Hz,2H,OCH2),3.02-2.94(m,2H,CH2CH2),2.55-2.51(m,2H,CH2CH2),1.68-1.58(m,2H,CH2CH2CH3),1.43-1.30(m,4H,2×CH2CH3),1.12(dd,J=15.0,7.5Hz,2H,CH2CH2CH3),0.90(t,J=7.4Hz,3H,CH3),0.77(t,J=7.4Hz,3H,CH3);MS(EI)m/z:448[M]+.
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(2-氯苯基)肼基-1-甲酸丁酯(B10)
Figure BSA0000155617530000151
黄褐色粉末,收率32.2%,m.p.92.1-93.2℃;IR(KBr,cm-1)v:3352,2971,2966,2928,2900,1767,1713,1620,1595,1501,1450;1H NMR(400MHz,DMSO)δ:7.80(s,1H,NH),7.31(dd,J=7.9,1.1Hz,1H,PhH),7.24-7.13(m,2H,PhH),6.83-6.75(m,1H,PhH),5.31(s,1H,C=CH2),4.93(s,1H,C=CH2),4.25(t,J=6.5Hz,2H,OCH2),3.93(t,J=6.3Hz,2H,OCH2),3.07-2.96(m,2H,CH2CH2),2.61-2.53(m,2H,CH2CH2),1.70-1.59(m,2H,CH2CH2CH3),1.38(ddd,J=17.5,10.9,5.1Hz,4H,2×CH2CH3),1.13(dt,J=14.3,7.3Hz,2H,CH2CH2CH3),0.90(t,J=7.4Hz,3H,CH3),0.77(t,J=7.4Hz,3H,CH3);MS(EI)m/z:464[M]+.
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(3-氯苯基)肼基-1-甲酸丁酯(B11)
Figure BSA0000155617530000152
红棕色粉末,收率51.1%,m.p.90.1-90.7℃;IR(KBr,cm-1)v:3300,2960,2933,2892,2873,1775,1715,1621,1598,1567,1480;1H NMR(600MHz,DMSO)δ:8.42(s,1H,NH),7.15(t,J=8.0Hz,1H,PhH),6.91(t,J=2.1Hz,1H,PhH),6.81-6.72(m,2H,PhH),5.24(s,1H,C=CH2),4.82(s,1H,C=CH2),4.24(t,J=6.6Hz,2H,OCH2),3.95(t,J=6.4Hz,2H,OCH2),3.01-2.97(m,2H,CH2CH2),2.55-2.52(m,2H,CH2CH2),1.64(dt,J=14.3,6.6Hz,2H,CH2CH2CH3),1.43-1.33(m,4H,2×CH2CH3),1.14(dd,J=15.0,7.4Hz,2H,CH2CH2CH3),0.90(t,J=7.4Hz,3H,CH3),0.78(t,J=7.4Hz,3H,CH3);MS(EI)m/z:464[M]+.
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-溴苯基)肼基-1-甲酸丁酯(B12)
Figure BSA0000155617530000153
淡红色粉末,收率47.2%,m.p.96.4-97.6℃;IR(KBr,cm-1)v:3374,2971,2966,2921,2900,1771,1722,1655,1594,1490,1473;1H NMR(400MHz,DMSO)δ:8.35(s,1H,NH),7.29(d,J=8.8Hz,2H,PhH),6.80(d,J=8.9Hz,2H,PhH),5.24(s,1H,C=CH2),4.84(s,1H,C=CH2),4.23(t,J=6.6Hz,2H,OCH2),3.94(t,J=6.4Hz,2H,OCH2),3.04-2.94(m,2H,CH2CH2),2.53(dd,J=5.1,2.2Hz,2H,CH2CH2),1.70-1.57(m,2H,CH2CH2CH3),1.44-1.28(m,4H,2×CH2CH3),1.13(dd,J=15.0,7.4Hz,2H,CH2CH2CH3),0.90(t,J=7.4Hz,3H,CH3),0.77(t,J=7.4Hz,3H,CH3);MS(EI)m/z:508[M]+.
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-甲苯基)肼基-1-甲酸丁酯(B13)
Figure BSA0000155617530000161
棕色粉末,收率32.7%,m.p.80.0-80.8℃;IR(KBr,cm-1)v:3338,2961,2929,2891,2873,1773,1697,1655,1614,1515,1460;1H NMR(400MHz,DMSO)δ:7.93(s,1H,NH),6.95(d,J=8.2Hz,2H,PhH),6.72(d,J=8.3Hz,2H,PhH),5.23(s,1H,C=CH2),4.81(s,1H,C=CH2),4.24(t,J=6.6Hz,2H,OCH2),3.92(t,J=6.4Hz,2H,OCH2),3.07-2.89(m,2H,CH2CH2),2.53(d,J=3.1Hz,2H,CH2CH2),2.17(s,3H,PhCH3),1.73-1.50(m,2H,CH2CH2CH3),1.45-1.23(m,4H,2×CH2CH3),1.12(dd,J=14.9,7.4Hz,2H,CH2CH2CH3),0.90(t,J=7.4Hz,3H,CH3),0.76(t,J=7.4Hz,3H,CH3);MS(EI)m/z:444[M]+.
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-甲氧基苯基)肼基-1-甲酸丁酯(B14)
Figure BSA0000155617530000162
棕色粉末,收率26.3%,m.p.82.8-83.3℃;IR(KBr,cm-1)v:3316,2961,2933,2874,2835,1773,1721,1693,1616,1511,1468;1H NMR(400MHz,DMSO)δ:7.77(s,1H,NH),6.81-6.72(m,4H,PhH),5.25(s,1H,C=CH2),4.83(s,1H,C=CH2),4.24(t,J=6.6Hz,2H,OCH2),3.92(t,J=6.4Hz,2H,OCH2),3.65(s,3H,OCH3),3.01-2.94(m,2H,CH2CH2),2.55-2.51(m,2H,CH2CH2),1.69-1.59(m,2H,CH2CH2CH3),1.37(dt,J=15.0,7.4Hz,4H,2×CH2CH2CH2CH3),1.13(dd,J=15.0,7.4Hz,2H,CH2CH2CH3),0.90(t,J=7.4Hz,3H,CH2CH3),0.77(t,J=7.4Hz,3H,CH2CH3);MS(E1)m/z:460[M]+.
用途实施例
实施例2:本发明的含二取代肼基的酯类化合物(I)对植物病原真菌的杀菌活性测
采用菌丝生长速率法(具体测定方法的参考文献:Chem.Res.Chin.Univ.2015,31(2):228-234.)测定了实施例1中所制备的含二取代肼基的酯类化合物(1)中的A、B系列化合物对四种供试植物病原菌小麦赤霉病菌(Fusarium graminearum)、蔬菜灰霉病菌(Botrytis cinerea)、水稻纹枯病菌(Rhizoctonia solani)和辣椒炭疽病菌(Colletotrichum capsici)在10μg/mL浓度下的杀菌活性,以多菌灵、速克灵、嘧菌酯作为对照药剂,测定结果见表1。
表1显示,在10μg/mL浓度下,含二取代肼基的酯类化合物(I)中的A、B系列化合物对四种供试植物病原菌小麦赤霉病菌、蔬菜灰霉病菌、水稻纹枯病菌和辣椒炭疽病菌具有显著的杀菌活性。其中,化合物A1-A8、A10、A12、A16-A23、B1、B2、B4-B7、B9、B11-B13对小麦赤霉病菌的抑制率大于90%;化合物A1-A6、A12、A14、A16-A20、A22、B8、B9、B11、B12对蔬菜灰霉病菌的抑制率大于90%;化合物A1、A3、A4、A9、A11-A16、A18-A20、A22、A23、B1、B2、B4-B11对水稻纹枯病菌的抑制率大于90%;化合物A1-A7、A11-A20、A22、B1、B2、B4-B8、B11、B12对辣椒炭疽病菌的抑制率大于90%。
表1 含二取代肼基的酯类化合物(I)对4种植物病原菌的抑制率(10μg/mL)
Figure BSA0000155617530000171

Claims (4)

1.式(I)所示结构的含二取代肼基的酯类化合物,
Figure FSB0000198804930000011
其中,
R1选自氢、甲基;
R2选自氢;
R3选自甲基、乙基、丙基、异丙基、丁基、异丁基、苯甲基;
Z选自N-R4,所述的R4选自氢、甲基、乙基、环丙基、环己基、乙酰基、苯甲基;
Y(n)选自2-氟、4-氟、2-氯、3-氯、4-氯、4-溴、2,4-二氯、4-甲基、3,4-二甲基、4-甲氧基;
或者,
R1选自氢;
R2选自氢;
R3选自甲基、乙基、丙基、异丙基、丁基、异丁基、苄基;
Z选自CH-R5,所述的R5选自氢;
Y(n)选自2-氟、4-氟、2-氯、3-氯、4-氯、4-溴、4-甲基、4-甲氧基。
2.根据权利要求1所述的含二取代肼基的酯类化合物,其特征在于其为如下所述化合物之一:
1-(1-(4-((甲氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸甲酯、
1-(1-(4-((乙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸乙酯、
1-(1-(4-((丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((丁氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丁酯、
1-(1-(4-((异丁氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丁酯、
1-(1-(4-((苄氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸苄酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-甲基苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-甲氧基苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(3,4-二甲基苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2-氟苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氟苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(3-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(2,4-二氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-溴苯基)肼基-1-甲酸异丙酯、
1-(1-(1-甲基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-乙基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-乙酰基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-环丙基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-环己基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(1-苄基-4-((异丙氧基甲酰基)氧基)-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(4-((异丙氧基甲酰基)氧基)-5-甲基-2-氧-2,5-二氢-1H-吡咯-3-基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(2-((甲氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸甲酯、
1-(1-(2-((乙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸乙酯、
1-(1-(2-((丙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丙酯、
1-(1-(2-((异丙氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丙酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸丁酯、
1-(1-(2-((异丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸异丁酯、
1-(1-(2-((苄氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氯苯基)肼基-1-甲酸苄酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(2-氟苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-氟苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(2-氯苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(3-氯苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-溴苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-甲苯基)肼基-1-甲酸丁酯、
1-(1-(2-((丁氧基甲酰基)氧基)-5-氧环戊-1-烯基)乙烯基)-2-(4-甲氧基苯基)肼基-1-甲酸丁酯。
3.一种制备权利要求1-2中任一项所述的含二取代肼基的酯类化合物的方法,其特征在于按通式(A)表示的方法制备:
Figure FSB0000198804930000021
其中在上述各结构式中:
R1、R2、R3、Z、Y(n)均具有权利要求1-2任一项中所述的含义。
4.权利要求1-2中任一项所述的含二取代肼基的酯类化合物在防治小麦赤霉病、蔬菜灰霉病、水稻纹枯病和辣椒炭疽病方面的应用。
CN201711343509.6A 2017-12-11 2017-12-11 一种含二取代肼基的酯类化合物、制备方法及应用 Expired - Fee Related CN109897001B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711343509.6A CN109897001B (zh) 2017-12-11 2017-12-11 一种含二取代肼基的酯类化合物、制备方法及应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711343509.6A CN109897001B (zh) 2017-12-11 2017-12-11 一种含二取代肼基的酯类化合物、制备方法及应用

Publications (2)

Publication Number Publication Date
CN109897001A CN109897001A (zh) 2019-06-18
CN109897001B true CN109897001B (zh) 2022-09-16

Family

ID=66943139

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711343509.6A Expired - Fee Related CN109897001B (zh) 2017-12-11 2017-12-11 一种含二取代肼基的酯类化合物、制备方法及应用

Country Status (1)

Country Link
CN (1) CN109897001B (zh)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101863820A (zh) * 2010-06-18 2010-10-20 南京农业大学 3-酰基吡咯烷-2,4-二酮缩氨基脲类化合物及其制备方法和用途
CN102993182A (zh) * 2012-12-28 2013-03-27 南京农业大学 一种含吡啶肼基团的吡咯烷二酮类化合物、制备方法及其应用
CN103183628A (zh) * 2011-12-30 2013-07-03 南京农业大学 一种含取代苯肼的吡咯烷-2,4-二酮类化合物、制备方法及应用
CN103641803A (zh) * 2013-12-30 2014-03-19 南京农业大学 一种含取代苯肼的呋喃二酮类化合物、制备方法及应用
CN104761521A (zh) * 2006-12-04 2015-07-08 拜尔农作物科学股份公司 联苯基取代的螺环酮-烯醇

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104761521A (zh) * 2006-12-04 2015-07-08 拜尔农作物科学股份公司 联苯基取代的螺环酮-烯醇
CN101863820A (zh) * 2010-06-18 2010-10-20 南京农业大学 3-酰基吡咯烷-2,4-二酮缩氨基脲类化合物及其制备方法和用途
CN103183628A (zh) * 2011-12-30 2013-07-03 南京农业大学 一种含取代苯肼的吡咯烷-2,4-二酮类化合物、制备方法及应用
CN102993182A (zh) * 2012-12-28 2013-03-27 南京农业大学 一种含吡啶肼基团的吡咯烷二酮类化合物、制备方法及其应用
CN103641803A (zh) * 2013-12-30 2014-03-19 南京农业大学 一种含取代苯肼的呋喃二酮类化合物、制备方法及应用

Also Published As

Publication number Publication date
CN109897001A (zh) 2019-06-18

Similar Documents

Publication Publication Date Title
US6699818B1 (en) Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
AU690190B2 (en) Pesticides
RU2294925C2 (ru) Пирролкарбоксамиды и амиды пирролтиокарбоновой кислоты и их использование в агрохимии
EP1035122B1 (en) Heterocyclic subsituted isoxazolidines and their use as fungicides
RU2228619C2 (ru) Средство защиты зерновых культур от фитотоксичного побочного действия гербицидов, соединение, способ его получения, способ борьбы с нежелательной растительностью
RU2264388C2 (ru) Трифторметилпирролкарбоксамиды
HU218298B (en) 2-[(dihydro)pyrazol 3'-yl-oxymethyl]-anilide-derivatives, intermediates, preparation thereof, pesticide and fungicide compositions containing these compounds and use thereof
MX2008015246A (es) Derivados de n-(1-alquil-2-feniletil)-carboxamida y uso de los mismos como fungicidas.
CS203016B2 (en) Fungicide and method of producing active compounds
EA020376B1 (ru) Новые фунгицидно активные пиразолкарбоксамиды
MXPA05003899A (es) Derivados de heterociclocarboxamidas.
JP2008515830A (ja) 活性成分の殺菌組み合わせ
TW200911780A (en) Fungicide heterocyclyl-pyrimidinyl-amino derivatives
CN112218860A (zh) 取代的苯硫基尿嘧啶、其盐及其作为除草剂的用途
TW568908B (en) Oxadiazoline derivatives and their use
CN103183628B (zh) 一种含取代苯肼的吡咯烷-2,4-二酮类化合物、制备方法及应用
HU183082B (en) Fungicide compositions containing alpha-phenoxy-alpha-triazolyl-acetic acid derivatives and process for preparing alpha-phenoxy-alpha-triazolyl-acetic acid derivatives
US20190367445A1 (en) 4-amino substituted phenylamidine derivatives and their use to protect crops by fighting undesired phytopathogenic micoorganisms
CN109897001B (zh) 一种含二取代肼基的酯类化合物、制备方法及应用
JP2020527562A (ja) 置換3−ヘテロアリールオキシ−1h−ピラゾール類及びそれらの塩、並びに、それらの除草活性物質としての使用
JPH02180866A (ja) 複素環式置換α―アリール―アクリル酸メチルエステル、ならびに該化合物を含有する殺菌剤および殺虫剤
CN103755618A (zh) 一种含n-取代苯肼的吡咯烷-2,4-二酮类化合物、制备方法及应用
JPS62277353A (ja) N−置換ピロリジン−及びピペリジン誘導体、その製法並びに該化合物を含有する殺菌剤
JP2020527565A (ja) 置換5−(ヘタ−)アリールピラゾールアミド類及びそれらの塩、並びに、それらの除草活性物質としての使用
CN112154147A (zh) 取代的苯硫基尿嘧啶、其盐及其作为除草剂的用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20220916